Moreover, we explored the UALCAN bioinformatics tool, and validated increased expressions of MYC/CXCL8/TIMP1 oncogenic signatures in CRC primary tumors and compared them to adjacent normal samples. This evidence concerns the gene TIMP1 and colorectal carcinoma.